How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions

Med J Aust. 2021 Feb;214(2):69-73.e1. doi: 10.5694/mja2.50907. Epub 2021 Jan 7.

Authors

Katy Jl Bell¹, Fiona F Stanaway¹, Les M Irwig¹, Andrea R Horvath², Armando Teixeira-Pinto^{1

3}, Clement Loy^{1

4}

Affiliations

¹ University of Sydney, Sydney, NSW.
² Prince of Wales Hospital and Community Health Services, Sydney, NSW.
³ Centre for Kidney Research, Westmead Millennium Institute for Medical Research, Sydney, NSW.
⁴ Westmead Hospital, Sydney, NSW.

PMID: 33415725
DOI: 10.5694/mja2.50907

No abstract available

Keywords: COVID-19; Diagnostic tests and procedures; Evidence-based medicine; Infectious diseases; Respiratory tract infections.

MeSH terms

COVID-19 / diagnosis*
COVID-19 Testing / standards*
Clinical Decision-Making*
Humans
Medical History Taking
SARS-CoV-2
Sensitivity and Specificity